FEE SCHEDULES

Are Commercial Payers Citing Proposed CMS Gapfill Rates, Trying to Negotiate Lower Reimbursement?

During the summer, the Centers for Medicare & Medicaid Services (CMS) published proposed interim gapfill prices for 15 molecular tests. The agency said it would likely publish final prices later … [Read more...]

ENFORCEMENT

CMS Bars Theranos’ California Lab from Medicare Program

Elizabeth Holmes dropped out of college to start up Theranos. Now Theranos and Holmes have been dropped from the Medicare program. Theranos has confirmed that the Centers for Medicare & Medicaid … [Read more...]

ENFORCEMENT

CMS Scrutiny Continues for Theranos

By Ron Shinkman, Editor, Laboratory Industry Report The Theranos saga has just entered its most critical state, as the Centers for Medicare & Medicaid Services (CMS) recommended the company's … [Read more...]

Two Prominent Senators Push CMS to Make Changes on PAMA Rules

The Congressional pressure on the Centers for Medicare & Medicaid Services to make changes to its proposed final rules on the Protecting Access to Medicare Act (PAMA) have been ramped up, with two … [Read more...]

Two Prominent Senators Push CMS to Make Changes on PAMA Rules

The Congressional pressure on the Centers for Medicare & Medicaid Services to make changes to its proposed final rules on the Protecting Access to Medicare Act (PAMA) have been ramped up, with two … [Read more...]

Palmetto Issues New Codes For BRCA, “Hotspot” Testing

Medicare fiscal intermediary Palmetto GBA quietly released new payment guidelines last month for several molecular tests under its MolDx program. Palmetto issued new codes related to BRCA testing, … [Read more...]

Congressional Members Lobby CMS on PAMA Regulations

Forty-four members of House of Representatives last month asked the Centers for Medicare & Medicaid Services (CMS) to make significant changes in how the Protecting Access to Medicare Act (PAMA) … [Read more...]

CMS Relents on Crosswalking Molecular Codes For 2016 CLFS

The feds have walked back the crosswalk. That was the news that awaited the laboratory sector late last month, when the Centers for Medicare & Medicaid Services (CMS) released its final molecular … [Read more...]

ACLA, AHA Submit Comments to CMS Regarding PAMA Final Rules

The laboratory and hospital sector's primary lobbies have submitted comments to the Centers for Medicare & Medicaid Services prior to the agency finalizing regulations for the Protecting Access to … [Read more...]

At Lab Institute, Thorny Reimbursement Dilemmas Weigh Heavily On Heads

If there is an unwritten code about industry gatherings, it is that civility rules the day. But a verbal scrap at G2 Intelligence's Laboratory Institute in Washington earlier this month highlighted … [Read more...]


(-00000g2)